These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
542 related items for PubMed ID: 22477262
1. 18F-FLT PET performs better than 18F-FDG PET in differentiating malignant uterine corpus tumors from benign leiomyoma. Yamane T, Takaoka A, Kita M, Imai Y, Senda M. Ann Nucl Med; 2012 Jul; 26(6):478-84. PubMed ID: 22477262 [Abstract] [Full Text] [Related]
3. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. Buck AK, Halter G, Schirrmeister H, Kotzerke J, Wurziger I, Glatting G, Mattfeldt T, Neumaier B, Reske SN, Hetzel M. J Nucl Med; 2003 Sep; 44(9):1426-31. PubMed ID: 12960187 [Abstract] [Full Text] [Related]
4. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. Chen W, Cloughesy T, Kamdar N, Satyamurthy N, Bergsneider M, Liau L, Mischel P, Czernin J, Phelps ME, Silverman DH. J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304 [Abstract] [Full Text] [Related]
5. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer? Schaefferkoetter JD, Carlson ER, Heidel RE. J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746 [Abstract] [Full Text] [Related]
6. Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer. van Westreenen HL, Cobben DC, Jager PL, van Dullemen HM, Wesseling J, Elsinga PH, Plukker JT. J Nucl Med; 2005 Mar; 46(3):400-4. PubMed ID: 15750150 [Abstract] [Full Text] [Related]
7. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study. Vera P, Bohn P, Edet-Sanson A, Salles A, Hapdey S, Gardin I, Ménard JF, Modzelewski R, Thiberville L, Dubray B. Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487 [Abstract] [Full Text] [Related]
8. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions. Okada M, Shimono T, Komeya Y, Ando R, Kagawa Y, Katsube T, Kuwabara M, Yagyu Y, Kumano S, Imaoka I, Tsuchiya N, Ashikaga R, Hosono M, Murakami T. Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526 [Abstract] [Full Text] [Related]
9. Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer. Yamamoto Y, Nishiyama Y, Ishikawa S, Nakano J, Chang SS, Bandoh S, Kanaji N, Haba R, Kushida Y, Ohkawa M. Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1610-6. PubMed ID: 17530250 [Abstract] [Full Text] [Related]
10. Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET. Kameyama R, Yamamoto Y, Izuishi K, Takebayashi R, Hagiike M, Murota M, Kaji M, Haba R, Nishiyama Y. Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):382-8. PubMed ID: 18985344 [Abstract] [Full Text] [Related]
11. 3'-Deoxy-3'-18F-fluorothymidine as a proliferation imaging tracer for diagnosis of lung tumors: comparison with 2-deoxy-2-18f-fluoro-D-glucose. Yamamoto Y, Nishiyama Y, Ishikawa S, Gotoh M, Bandoh S, Kanaji N, Asakura M, Ohkawa M. J Comput Assist Tomogr; 2008 Mar; 32(3):432-7. PubMed ID: 18520552 [Abstract] [Full Text] [Related]
12. [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer. Been LB, Hoekstra HJ, Suurmeijer AJ, Jager PL, van der Laan BF, Elsinga PH. Oral Oncol; 2009 Dec; 45(12):e211-5. PubMed ID: 19692292 [Abstract] [Full Text] [Related]
13. Detection of colorectal cancer using ¹⁸F-FLT PET: comparison with ¹⁸F-FDG PET. Yamamoto Y, Kameyama R, Izuishi K, Takebayashi R, Hagiike M, Asakura M, Haba R, Nishiyama Y. Nucl Med Commun; 2009 Nov; 30(11):841-5. PubMed ID: 19773672 [Abstract] [Full Text] [Related]
15. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes. Rayamajhi SJ, Mittal BR, Maturu VN, Agarwal R, Bal A, Dey P, Shukla J, Gupta D. Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845 [Abstract] [Full Text] [Related]
16. Additional value of 16α-[18F]fluoro-17β-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [18F]fluorodeoxyglucose PET. Yoshida Y, Kiyono Y, Tsujikawa T, Kurokawa T, Okazawa H, Kotsuji F. Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1824-31. PubMed ID: 21656049 [Abstract] [Full Text] [Related]
17. Prognostic Value of 18F-FLT PET in Patients with Neuroendocrine Neoplasms: A Prospective Head-to-Head Comparison with 18F-FDG PET and Ki-67 in 100 Patients. Johnbeck CB, Knigge U, Langer SW, Loft A, Berthelsen AK, Federspiel B, Binderup T, Kjaer A. J Nucl Med; 2016 Dec; 57(12):1851-1857. PubMed ID: 27469355 [Abstract] [Full Text] [Related]
18. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts]. Liu X, Zhou NK, Zhang JM, Liang ZY, Zheng X. Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377 [Abstract] [Full Text] [Related]
19. Uterine tumors: pathophysiologic imaging with 16alpha-[18F]fluoro-17beta-estradiol and 18F fluorodeoxyglucose PET--initial experience. Tsujikawa T, Yoshida Y, Mori T, Kurokawa T, Fujibayashi Y, Kotsuji F, Okazawa H. Radiology; 2008 Aug; 248(2):599-605. PubMed ID: 18539894 [Abstract] [Full Text] [Related]
20. Differential (18)F-FDG and (18)F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung Cancer. Everitt SJ, Ball DL, Hicks RJ, Callahan J, Plumridge N, Collins M, Herschtal A, Binns D, Kron T, Schneider M, MacManus M. J Nucl Med; 2014 Jul; 55(7):1069-74. PubMed ID: 24833494 [Abstract] [Full Text] [Related] Page: [Next] [New Search]